Simultaneous Analysis and Pharmacokinetics of Plasma Loratadine and Pseudoephedrine by LC-MS

WANG Wei,WANG Guang-ji,SUN Jian-guo,XIE Hai-tang,LI Hao,JIANG Xi-ling,GU Yi,ZHANG Jin-wen,HUANG Min-wen
DOI: https://doi.org/10.3321/j.issn:1003-3734.2005.07.029
2005-01-01
Abstract:Objective:To assess pharmacokinetics of loratadine and pseudoephedrine in healthy volunteers, following after the establishment of a LC-MS method for the simultaneous determination of plasma loratadine and pseudoephedrine. Methods:A randomized and crossover doses clinical study recruited 20 healthy volunteers, who were orally administrated with a single dose or multiple doses of loratadine and pseudoephedrine. The plasma samples from the volunteers were obtained by alkalization and liquid-liquid extraction. A liquid chromatography-mass spectrum (LC-MS) equipped with electrospray ionization (ESI) source was used to assay the plasma samples. The LC-MS was conducted under a Hypersil-ODS column and the mobile eluent of CH_3CN-0.02%NH_4Ac (80∶20). The bioavailability of loratadine and pseudoephedrine was determined by using the LC-MS.Results:The calibrated linear curve was in the range of 0.5~5.0 ng.mL -1 for loratadine and 5.0~ 1 000.0ng·mL -1 for pseudoephedrine (r= 0.999 9,r= 0.999 8) with the detection limit of 0.5 ng·mL -1 and 5.0 ng·mL -1, respectively. The test capsules of loratadine and pseudoephedrine were bioequivalent to the reference tablets of loratadine and pseudoephedrine.Conclusion:This specific, sensitive and reliable LC-MS method offers an alternative to monitor and evaluate the pharmacokinetics of loratadine and pseudoephedrine.
What problem does this paper attempt to address?